Cargando…
Impact of the COVID-19 Pandemic on ROSE Utilization and Final Diagnostic, PD-L1 Immunohistochemistry, and Molecular Testing Yields of CT-guided Lung Biopsies
Autores principales: | Jennings, Emma, Gutmann, Edward, Percarpio, Robert, Marotti, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581508/ http://dx.doi.org/10.1016/j.jasc.2022.07.152 |
Ejemplares similares
-
Percutaneous CT-Guided Biopsy of the Craniovertebral Junction: Safety, Diagnostic Yield, and Technical Notes
por: Spinnato, Paolo, et al.
Publicado: (2022) -
Non-Diagnostic CT-Guided Percutaneous Needle Biopsy of the Lung: Predictive Factors and Final Diagnoses
por: Tongbai, Thanisa, et al.
Publicado: (2019) -
CT-Guided Core Needle Biopsy of Pleural Lesions: Evaluating Diagnostic Yield and Associated Complications
por: Niu, Xiang-Ke, et al.
Publicado: (2015) -
Diagnostic yield of CT-guided lung biopsies: how can we limit negative sampling?
por: Tipaldi, Marcello Andrea, et al.
Publicado: (2022) -
Improving CT-guided transthoracic biopsy diagnostic yield of lung masses using intraprocedural CT and prior PET/CT fusion imaging
por: Lin, Yue, et al.
Publicado: (2022)